Report Highlights New Environmental Sustainability Goals and Impact on Global Health
KENILWORTH, N.J., November 2, 2017 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, today published its 2016/2017 Corporate Responsibility Report. The report reflects the company’s performance in the areas of Access to Health, Employees, Environmental Sustainability and Ethics & Transparency.
In today’s ever-changing healthcare environment, new and creative solutions are needed to accelerate advances in global health and development. Pfizer is responding to this new global picture by focusing on locally driven and collaborative approaches that aim to break down healthcare access barriers, address the health needs of individuals and support long-term capacity building.
PYXERA Global is Hosting Fall Virtual Event Series on the Youth Skills Gap, Post-Harvest Loss, and Treatable and Preventable NCDs
WASHINGTON, July 26, 2017 /3BL Media/ -The time is now to engage partners, begin collaborations, scale solutions, and make progress on solvable problems such as reducing post-harvest loss, bridging youth skills gap and increasing employability, and treating and preventing non-communicable diseases (NCDs). PYXERA Global will host a #GEFlive fall virtual event series on those three solvable problems, starting in September.
Pfizer and its incredible network of partners dedicated to the fight against trachoma recently came together at the Neglected Tropical Diseases (NTDs) Summit 2017 in Geneva, Switzerland to celebrate the five-year anniversary of the
Neglected Tropical Diseases (NTDs) affect more than 1 billion people, mostly in poor and developing areas. They are both a consequence and a cause of poverty, thriving where access to clean water, sanitation and healthcare is limited.
Bridging the gap between food and agriculture and public health
More than five years have passed since the 2011 United Nations high-level meeting on the Prevention and Control of Non-communicable Diseases (NCDs). NCDs such as cardiovascular disease, cancer, diabetes, and chronic lung disease are a leading cause of mortality worldwide, responsible for more than 30 million deaths annually. These diseases alone place an enormous burden on health systems, representing $2 trillion a year in health costs, and the projected toll in lost economic output by 2030 is a staggering $47 trillion.
Takeaways from the PYXERA Global Engagement Forum: Live
WASHINGTON, D.C., April 7, 2017 /3BL Media/ – PYXERA Global and partners convened more than 200 leaders and innovators at the Global Engagement Forum: Live in Washington, D.C on April 4 and 5. The two-day Forum dove into global challenges outlined by the Sustainable Development Goals (SDGs), specifically with regards to hunger (reducing post-harvest loss), global health, and youth employability.
Pfizer believes that all individuals deserve access to quality health care and the opportunity to lead healthy lives. We combine creative commercial strategies with philanthropic approaches to create a sustainable and meaningful impact on global health. In 2016, we made significant strides in advancing this goal, including: